ReviewJournal of translational medicine2025
CBP/p300, a promising therapeutic target for prostate cancer.
Hongtao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewJournal of translational medicine2025
Hongtao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.